Paper1900527
The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons.
Ben-Shachar D and 3 others. J Neurochem, 1991. Cited by 281 papers, by iCite.
Cite this record
ConductScience Library. The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. Papers, record 1900527. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1900527
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Deferoxamine | Major topic |
| Dopamine | Major topic |
| Hydroxydopamines | Major topic |
| Nerve Degeneration | Major topic |
| Neurons | Major topic |
| Substantia Nigra | Major topic |
| 3,4-Dihydroxyphenylacetic Acid | |
| Animals | |
| Homovanillic Acid | |
| Iron Chelating Agents | |
| Male | |
| Neurotoxins | |
| Oxidopamine | |
| Rats | |
| Rats, Inbred Strains |
Source PubMed
Cited by70
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 281 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41977458 | Acidosis, Iron Dyshomeostasis and Inflammatory Injury. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977458 | PubMed |
| 41258873 | Pathogenic mechanism underlying parkinsonism induced by neurotoxicants (MPTP and 6-hydroxydopamine) and α-synuclein: a unifying hypothesis. | J Mol Cell Biol | 2025 | https://conductscience.org/library/papers/41258873 | PubMed |
| 38731800 | The Role of Oxygen Homeostasis and the HIF-1 Factor in the Development of Neurodegeneration. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38731800 | PubMed |
| 37892438 | Roles of Omega-3 Polyunsaturated Fatty Acids in Managing Cognitive Impairment in Chronic Obstructive Pulmonary Disease: A Review. | Nutrients | 2023 | https://conductscience.org/library/papers/37892438 | PubMed |
| 37062012 | Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson's disease. | J Neural Transm (Vienna) | 2023 | https://conductscience.org/library/papers/37062012 | PubMed |
| 36106206 | Depression in Parkinson's Disease: A Narrative Review. | Cureus | 2022 | https://conductscience.org/library/papers/36106206 | PubMed |
| 35922689 | LUHMES Dopaminergic Neurons Are Uniquely Susceptible to Ferroptosis. | Neurotox Res | 2022 | https://conductscience.org/library/papers/35922689 | PubMed |
| 35054862 | Mechanistic Insights Expatiating the Redox-Active-Metal-Mediated Neuronal Degeneration in Parkinson's Disease. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35054862 | PubMed |
| 34721835 | Neuroprotective Effects of Estradiol plus Lithium Chloride via Anti-Apoptosis and Neurogenesis Pathway in In Vitro and In Vivo Parkinson's Disease Models. | Parkinsons Dis | 2021 | https://conductscience.org/library/papers/34721835 | PubMed |
| 34299316 | Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer's Disease. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34299316 | PubMed |
| 33799121 | Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies. | Redox Biol | 2021 | https://conductscience.org/library/papers/33799121 | PubMed |
| 33419006 | Inflaming the Brain with Iron. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/33419006 | PubMed |
| 33028106 | The Association Between Parkinson's Disease and Attention-Deficit Hyperactivity Disorder. | Cell Transplant | 2020 | https://conductscience.org/library/papers/33028106 | PubMed |
| 32650609 | The Role of Oxidative Stress in Parkinson's Disease. | Antioxidants (Basel) | 2020 | https://conductscience.org/library/papers/32650609 | PubMed |
| 32424108 | Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson's disease through AKT/mTOR pathway. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/32424108 | PubMed |
| 31960628 | Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non-disease-specific pathway of functional neurologic improvement. | Brain Behav | 2020 | https://conductscience.org/library/papers/31960628 | PubMed |
| 31894418 | 6-Hydroxydopamine: a far from simple neurotoxin. | J Neural Transm (Vienna) | 2020 | https://conductscience.org/library/papers/31894418 | PubMed |
| 31440200 | Mobility Deficits Assessed With Mobile Technology: What Can We Learn From Brain Iron-Altered Animal Models? | Front Neurol | 2019 | https://conductscience.org/library/papers/31440200 | PubMed |
| 30341696 | Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases. | J Neural Transm (Vienna) | 2018 | https://conductscience.org/library/papers/30341696 | PubMed |
| 28984871 | How do we fit ferroptosis in the family of regulated cell death? | Cell Death Differ | 2017 | https://conductscience.org/library/papers/28984871 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1900527
GET https://conductscience.org/api/papers/v1/1900527/cited_by?page=2